BHRT can cause side effects, but the type and likelihood of side effects depend on which hormone is used, the dose, the delivery method, your age, your health history, and how closely treatment is monitored. Bioidentical hormone replacement therapy uses hormones that match the structure of hormones naturally made by the body, such as estradiol, micronized progesterone, and testosterone. That can make treatment feel more physiologic for many patients, but “bioidentical” does not mean side-effect-free. A risk-aware practice separates expected adjustment symptoms from warning signs, uses the lowest effective dose, and adjusts the plan based on how your body responds.

Key Points

• Side effects are usually dose- or route-related. Breast tenderness, bloating, headaches, spotting, acne, skin irritation, mood shifts, or sleep changes may occur when starting or adjusting BHRT. Many of these improve with dose changes, route changes, or time.
• Estrogen side effects are different from progesterone side effects. Estradiol may cause breast tenderness, fluid retention, nausea, headaches, or spotting. Progesterone may cause sleepiness, vivid dreams, mood changes, bloating, or dizziness in some patients.
• Testosterone needs careful monitoring. In men, testosterone can raise hematocrit, which is the percentage of red blood cells in the blood. In women, too much testosterone can cause acne, oily skin, facial hair growth, scalp hair thinning, mood changes, or voice changes.
• Route matters, especially for estrogen. Oral estrogen passes through the liver first and has a different clotting and metabolic profile than transdermal estradiol. Patches, gels, and creams are often preferred in a risk-aware practice when clotting or cardiovascular considerations matter.
• Compounded BHRT requires thoughtful oversight. Compounded prescriptions can be useful when custom dosing or inactive-ingredient flexibility is needed. The final compounded formulation is not reviewed by the FDA the same way as a commercially manufactured drug, so pharmacy quality and monitoring matter.
• Serious side effects are uncommon but important. Chest pain, shortness of breath, one-sided weakness, sudden severe headache, vision changes, calf swelling, or heavy vaginal bleeding should be treated as urgent. These are not normal adjustment symptoms.

Understanding BHRT Side Effects

BHRT side effects happen for a few main reasons. The dose may be too high, the dose may be too low, the delivery method may not fit the patient, the hormone combination may need adjustment, or another health issue may be contributing to symptoms. This is why side effects should not be interpreted in isolation.

For example, breast tenderness after starting estrogen can sometimes mean the estrogen dose is too strong, progesterone balance needs attention, or the body is still adjusting. Spotting can occur in the early months of hormone therapy, especially when the uterine lining is adapting. Mood changes may relate to progesterone sensitivity, testosterone dose, sleep disruption, thyroid function, or stress physiology.

Side effects also differ depending on whether the hormone is systemic or local. Systemic therapy circulates throughout the body and is used for broader symptoms such as hot flashes, night sweats, sleep disruption, mood changes, bone support, or low testosterone. Local vaginal estrogen is used mainly for vaginal dryness, painful sex, urinary urgency, or recurrent urinary symptoms and generally has much lower systemic absorption.

The goal of BHRT is not to push hormones as high as possible. The goal is to restore enough hormone support to improve symptoms while minimizing side effects and risk. That requires follow-up, dose adjustment, and a willingness to change the plan when the body gives feedback.

Common Side Effects By Hormone

Different hormones produce different side effects. Understanding which hormone is most likely responsible helps the provider adjust the plan more intelligently instead of stopping everything at once or increasing doses blindly.

• Estradiol side effects: Possible side effects include breast tenderness, bloating, nausea, headaches, fluid retention, mood changes, and spotting or irregular bleeding. Skin patches may also cause local irritation. These effects may improve by lowering the dose, changing the route, adjusting progesterone, or giving the body time to adapt.
• Progesterone side effects: Micronized progesterone may feel calming or sleep-supportive for many women, but some experience grogginess, dizziness, vivid dreams, bloating, low mood, or irritability. Progesterone is often used for uterine protection when systemic estrogen is prescribed to a woman with a uterus. It may also be appropriate for some women who no longer have a uterus, especially when it supports sleep, mood, or overall hormone balance, but the reason for prescribing it is different than uterine protection and should be individualized.
• Testosterone side effects: In women, excess testosterone can cause acne, oily skin, unwanted facial hair growth, scalp hair thinning, irritability, or voice changes. In men, testosterone can raise hematocrit, worsen untreated sleep apnea, contribute to acne or fluid retention, and requires monitoring to keep levels in a safe physiologic range.
• Thyroid and adrenal overlap: Some symptoms blamed on BHRT may actually come from thyroid imbalance, blood sugar instability, stress, poor sleep, iron deficiency, low vitamin D, medication effects, or overtraining. A complete evaluation helps avoid blaming hormones for every symptom.

Side effects do not always mean BHRT is wrong for the patient. Sometimes they mean the treatment is close but needs refinement. A dose may need to be lowered, the route may need to change, progesterone timing may need adjustment, or testosterone may need to be reduced.

Why Route And Dose Matter

The way a hormone enters the body can change how it behaves. This is especially important with estrogen. Oral estrogen passes through the liver before reaching the rest of the body, which is called first-pass metabolism. That liver effect can influence clotting proteins, triglycerides, and other markers.

Transdermal estradiol, such as a patch, gel, or cream, enters through the skin and largely bypasses first-pass liver metabolism. This is one reason many risk-aware practices prefer transdermal estradiol, especially for patients with clotting risk factors, cardiovascular risk factors, migraine concerns, metabolic issues, or sensitivity to oral medications.

Vaginal estrogen is different from systemic estrogen. It is usually used for local genitourinary symptoms such as vaginal dryness, painful sex, urinary urgency, or recurrent urinary discomfort. Because systemic absorption is typically low, local therapy may be an option for some patients who are not candidates for full systemic estrogen, though that decision should still be individualized.

Testosterone also requires attention to route and dose. Injections, creams, gels, and pellets can produce different patterns in blood levels. If levels rise too high or fluctuate too much, side effects are more likely. Monitoring helps keep therapy in a physiologic range rather than a supraphysiologic range.

Who It’s For And Who Should Be Cautious

BHRT may be appropriate for women with bothersome perimenopause or menopause symptoms such as hot flashes, night sweats, poor sleep, mood changes, vaginal dryness, painful sex, brain fog, low libido, or changes in body composition. It may also be considered for bone support in properly selected patients. Side effects are less likely to become problematic when therapy is started with the right candidate, at the right time, with the right route and follow-up plan.

For men, testosterone replacement may be appropriate when symptoms are consistent with low testosterone and properly interpreted labs confirm hypogonadism. Newer research has challenged older assumptions that testosterone therapy automatically increases cardiovascular or prostate risk in appropriately selected and monitored men. That said, testosterone is not a casual wellness treatment and should not be used without a clear indication and monitoring plan.

People who need extra caution include those with a history of hormone-sensitive cancer, unexplained vaginal bleeding, blood clots, stroke, significant liver disease, uncontrolled high blood pressure, active cardiovascular disease, untreated sleep apnea, very high hematocrit, or complex medication histories. These situations do not always make hormone therapy impossible, but they change the risk-benefit conversation.

Women with a uterus need special attention if systemic estrogen is prescribed. Estrogen without adequate progesterone or another appropriate progestogen can stimulate the uterine lining and increase the risk of endometrial overgrowth. Any unexpected, heavy, persistent, or postmenopausal bleeding should be evaluated.

A good candidate for BHRT is not simply someone with symptoms. A good candidate is someone whose symptoms, history, lab findings, goals, and risk profile suggest that hormone therapy is likely to help more than it could harm.

Risks, Side Effects, and Monitoring

Most BHRT side effects are manageable when caught early. Breast tenderness, bloating, headaches, skin irritation, spotting, mood shifts, acne, or sleep changes should be reported rather than ignored. The solution may be as simple as changing the dose, adjusting timing, switching routes, or reassessing the hormone combination.

More serious risks depend on the hormone and the patient. Estrogen therapy may affect clotting risk, stroke risk, gallbladder risk, breast symptoms, and uterine lining safety depending on the route, dose, timing, duration, and whether progesterone is needed. Progesterone may cause sedation, dizziness, mood changes, or bloating in some patients. Testosterone may raise hematocrit, worsen acne or hair thinning, affect mood, or contribute to fluid retention if dosing is too high.

Monitoring should include more than hormone levels. A careful provider reviews symptom response, side effects, blood pressure, bleeding patterns, breast or prostate considerations when relevant, medication interactions, and appropriate labs. For women, follow-up may include adjusting estrogen route, progesterone timing, bleeding evaluation, and breast health screening as appropriate. For men, follow-up often includes testosterone levels, hematocrit, blood pressure, symptom response, and prostate-related considerations when appropriate.

Compounded BHRT should be monitored with the same seriousness as any other prescription. Compounding can be useful when individualized dosing is needed, but it should involve a reputable pharmacy, a clear clinical reason, and structured follow-up. Custom does not mean casual.

A practical rule is that the lowest effective dose should be used, and the plan should be revisited over time. Hormone needs can change with age, weight changes, surgery, new medications, stress, sleep, thyroid function, and evolving health risks.

Safety

Seek urgent medical care right away for chest pain, shortness of breath, one-sided weakness or numbness, sudden severe headache, vision changes, fainting, calf pain or swelling, coughing up blood, or heavy vaginal bleeding. These symptoms can signal rare but serious problems such as a blood clot, stroke, pulmonary embolism, or significant bleeding.

Call your provider for non-urgent but important issues such as persistent breast tenderness, mood changes, acne, scalp hair shedding, patch irritation, unexpected spotting, worsening sleep, swelling, or symptoms that worsen after starting therapy. Do not adjust your dose on your own. Hormone therapy should be changed with medical guidance, especially if you take medications for blood pressure, clotting, thyroid disease, diabetes, mood, seizures, or cardiovascular conditions.

If you are preparing for surgery, have a major illness or injury, or expect prolonged immobility or long-distance travel, tell your prescribing provider. Temporary risk factors can change the safety calculation, and your plan may need to be adjusted.

Sources and Citations

• Use of Menopausal Hormone Therapy Beyond Age 65 Years and Its Effects on Women’s Health Outcomes by Types, Routes, and Doses — Menopause
• Contemporary Menopausal Hormone Therapy and Risk of Cardiovascular Disease — BMJ
• The Benefits and Risks of Menopause Hormone Therapy for the Cardiovascular System in Postmenopausal Women — BMC Women’s Health
• Comparative Evidence Between Transdermal and Oral Menopausal Hormone Therapy — NCBI Bookshelf
• A Meta-Analysis of 30 Randomized Controlled Trials — Endocrine Practice
• Prostate Risk and Monitoring During Testosterone Replacement Therapy — JAMA Network Open